Home » GAO Probe of Drug Prices Requested by Congress
GAO Probe of Drug Prices Requested by Congress
November 20, 2009
Allegations that drugmakers are raising prices in anticipation of healthcare legislation that may reduce pharmaceutical costs or curb growth have led several
House committee leaders to request a Government Accountability Office (GAO) investigation on recent price trends.